Machine learning‐guided design of potent darunavir analogs targeting HIV ‐1 proteases: A computational approach for antiretroviral drug discovery
Journal of Computational Chemistry · 2024
DOI: 10.1002/jcc.27298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Computational Chemistry, 2024. Verfasst von Hathaichanok Chuntakaruk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: HIV-1, HIV Protease Inhibitors, HIV Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: Thailand Science research and Innovation Fund Chulalongkorn University (CU), The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund), The Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan through the Grant-in-Aid for Innovative Research "Mesohierarchy".
Abstract (Originalsprache)
In the pursuit of novel antiretroviral therapies for human immunodeficiency virus type‐1 (HIV‐1) proteases (PRs), recent improvements in drug discovery have embraced machine learning (ML) techniques to guide the design process. This study employs ensemble learning models to identify crucial substructures as significant features for drug development. Using molecular docking techniques, a collection of 160 darunavir (DRV) analogs was designed based on these key substructures and subsequently screened using molecular docking techniques. Chemical structures with high fitness scores were selected, combined, and one‐dimensional (1D) screening based on beyond Lipinski's rule of five (bRo5) and ADME (absorption, distribution, metabolism, and excretion) prediction implemented in the Combined Analog generator Tool (CAT) program. A total of 473 screened analogs were subjected to docking analysis through convolutional neural networks scoring function against both the wild‐type (WT) and 12 major mutated PRs. DRV analogs with negative changes in binding free energy () compared to DRV could be categorized into four attractive groups based on their interactions with the majority of vital PRs. The analysis of interaction profiles revealed that potent designed analogs, targeting both WT and mutant PRs, exhibited interactions with common key amino acid residues. This observation further confirms that the ML model‐guided approach effectively identified the substructures that play a crucial role in potent analogs. It is expected to function as a powerful computational tool, offering valuable guidance in the identification of chemical substructures for synthesis and subsequent experimental testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, Thailand.
- Department of Biochemistry, Faculty of Science, Center of Excellence in Structural and Computational Biology, Chulalongkorn University, Bangkok, Thailand.
- School of Information Science and Technology, Vidyasirimedhi Institute of Science and Technology (VISTEC), Rayong, Thailand.
- Center of Excellence in Natural Products Chemistry (CENP), Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
- Center for Computational Sciences, University of Tsukuba, Ibaraki, Japan.
- Department of Chemistry, Faculty of Science, Center of Excellence in Computational Chemistry (CECC), Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Hathaichanok Chuntakaruk
Förderung
- Thailand Science research and Innovation Fund Chulalongkorn University (CU)
- The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)
- The Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan through the Grant-in-Aid for Innovative Research "Mesohierarchy"
- Japan Agency for Science and Technology (JST) through the CREST program "Precise Arrangement Toward Functionality"
Zitieren
APA
Chuntakaruk, H., Boonpalit, K., Kinchagawat, J., Nakarin, F., Khotavivattana, T., Aonbangkhen, C., Shigeta, Y., Hengphasatporn, K., Nutanong, S., Rungrotmongkol, T., & Hannongbua, S. (2024). Machine learning‐guided design of potent darunavir analogs targeting HIV ‐1 proteases: A computational approach for antiretroviral drug discovery. Journal of Computational Chemistry. https://doi.org/10.1002/jcc.27298
Vancouver
Chuntakaruk H, Boonpalit K, Kinchagawat J, Nakarin F, Khotavivattana T, Aonbangkhen C, et al. Machine learning‐guided design of potent darunavir analogs targeting HIV ‐1 proteases: A computational approach for antiretroviral drug discovery. Journal of Computational Chemistry. 2024. doi:10.1002/jcc.27298
BibTeX
@article{Chuntakaruk2024,
author = {Chuntakaruk, Hathaichanok and Boonpalit, Kajjana and Kinchagawat, Jiramet and Nakarin, Fahsai and Khotavivattana, Tanatorn and Aonbangkhen, Chanat and Shigeta, Yasuteru and Hengphasatporn, Kowit and Nutanong, Sarana and Rungrotmongkol, Thanyada and Hannongbua, Supot},
title = {Machine learning‐guided design of potent darunavir analogs targeting HIV ‐1 proteases: A computational approach for antiretroviral drug discovery},
journal = {Journal of Computational Chemistry},
year = {2024},
doi = {10.1002/jcc.27298}
}
EUVIMED